🇺🇸 FDA
Patent

US 11370787

Pyrazole compounds, formulations thereof, and a method for using the compounds and/or formulations

granted A61PA61P29/00

Quick answer

US patent 11370787 (Pyrazole compounds, formulations thereof, and a method for using the compounds and/or formulations) held by Rigel Pharmaceuticals, Inc. expires Mon Jun 23 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Rigel Pharmaceuticals, Inc.
Grant date
Tue Jun 28 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 23 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
23
CPC classes
A61P, A61P29/00